Pacira BioSciences, Inc. — Director's Dealing 2018

Jun 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2018-06-04

Reporting Person: Reinhart Charles A. III (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-04	Common Stock	S	708	$33.02	Disposed	8042	Direct

Footnotes

F1: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.